Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinazolines as inhibitors of endothelin converting enzyme

Quinazolines as inhibitors of endothelin converting enzyme

US Patent 5658902 · Granted Aug 19, 1997

Estimated economic value: $49,636,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other use2025
Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other use2025
Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma2024
Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma2024
Biaryl amides with modified sugar groups for treatment of diseases associated wi2023
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulator2023
Treatment of idiopathic pulmonary fibrosis2023
C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses2023
Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other use2022
Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other use2022
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulator2021
Imidazolyl tricyclic enones as antioxidant inflammation modulators2021